TickerFacts.

Biodesix Inc (BDSX): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$23.27M
Year ended 2025-12-31
-$19.83M
Trailing 12 months to 2026-06-30
2019-12-31: -$21.73M2020-12-31: -$21.37M2021-12-31: -$28.22M2022-12-31: -$44.97M2023-12-31: -$22.87M2024-12-31: -$48.65M2025-12-31: -$23.27M-$23.27M
2019-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$23.27Mn/m2026-02-26, From 2025-01-01
2024-12-31-$48.65Mn/m2026-02-26, From 2024-01-01
2023-12-31-$22.87Mn/m2025-03-03, From 2023-01-01
2022-12-31-$44.97Mn/m2024-03-01, From 2022-01-01
2021-12-31-$28.22Mn/m2023-03-06, From 2021-01-01
2020-12-31-$21.37Mn/m2022-03-14, From 2020-01-01
2019-12-31-$21.73Mn/a2021-03-16, From 2019-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Biodesix Inc (BDSX)2025-12-31-$23.27Mn/m
Personalis, Inc. (PSNL)2025-12-31-$74.95Mn/m
Exagen Inc. (XGN)2025-12-31-$13.62Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$299.01Mn/m
American Shared Hospital Services (AMS)2025-12-31$3.10Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$24.59Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$101.64Mn/m
Castle Biosciences Inc (CSTL)2025-12-31$64.35M-0.8%
CareDx, Inc. (CDNA)2025-12-31$42.03M+10.5%

Compare BDSX, PSNL, XGN, GRAL side by side · Screen every company in Services-Medical Laboratories ↗